UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): December 17, 2004
IR BIOSCIENCES HOLDINGS, INC.
-----------------------------
(Exact name of registrant specified in charter)
Delaware 033-05384 13-3301899
------------------------ ------------------------ ----------------------
(State of (Commission File (IRS Employer
Incorporation) Number) Identification No.)
4021 N. 75th Street, Suite 201
Scottsdale, AZ 85251
--------------------
(Address of principal executive offices) (Zip Code)
(480) 922-3926
--------------
(Registrant's telephone number, including area code)
------------------------------
(Former name or former address, if changed since last report
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions (see General Instruction A.2. below):
[ ]Written communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
[ ]Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
[ ]Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange
Act (17 CFR 240.14d-2(b))
[ ]Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange
Act (17 CFR 240.13e-4(c))
ITEM 5.02 DEPARTURE OF DIRECTORS OR PRINCIPAL OFFICERS; ELECTION OF DIRECTORS;
APPOINTMENT OF PRINCIPAL OFFICERS.
(b) Effective December 17, 2004, Eric Hopkins, Chief Financial Officer, resigned
from his position with the Registrant.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
IR BioSciences Holdings, Inc.
Date: December 22, 2004 By: /s/ Michael Wilhelm
-----------------------------
Michael Wilhelm
President
(Duly Authorized Officer)